Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001638599-16-001082
Filing Date
2016-06-16
Accepted
2016-06-16 16:37:42
Documents
1
Period of Report
2016-06-15

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT doc4_4031.html 4  
1 PRIMARY DOCUMENT doc4_4031.xml 4 3277
  Complete submission text file 0001638599-16-001082.txt   4728
Mailing Address 21 CORPORATE CIRCLE P O BOX 15098 ALBANY NY 12203-5154
Business Address 21 CORPORATE CIRCLE P O BOX 15098 ALBANY NY 12203-5154 5184640279
ALBANY MOLECULAR RESEARCH INC (Issuer) CIK: 0001065087 (see all company filings)

EIN.: 141742717 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address C/O SORRENTO THERAPEUTICS, INC. 6042 CORNERSTONE CT. WEST SUITE B SAN DIEGO CA 92121
Business Address
Deming David H (Reporting) CIK: 0001641063 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35622 | Film No.: 161717958